Jefferies Initiates Coverage On Vicore Pharma Holding with Buy Rating, Announces Price Target of $25
Jefferies analyst Faisal Khurshid initiates coverage on Vicore Pharma Holding (NASDAQ:VCRE) with a Buy rating and announces Price Target of $25.
Stocks · News reference
Vicore Pharma to Participate in Upcoming Healthcare Conferences
Vicore Pharma Holding AB announced its participation in the Guggenheim 3rd Annual Healthcare Innovation Conference and the Stifel 2026 Healthcare Conference in November 2026.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Evolution Metals & Technologies, Barfresh Food Group, Snap And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
U.S. stock futures were mixed this morning, with the Nasdaq 100 futures up 150 points. Evolution Metals & Technologies Corp (EMAT) drops in pre-market trading due to weak sales. Other stocks, such as BRFH, SNAP, and VCRE also decline.
Why HIVE Digital Technologies Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
HIVE Digital Technologies Ltd (NASDAQ: HIVE) rose in pre-market trading due to its subsidiary's new agreement. Other gainers include IP Strategy Holdings, INVO Fertility, My Size, Trugolf Holdings, Expion360, Skye Bioscience, Julong Holding, FIEE Inc, and Keel Infrastructure. Losers include Generation Income Properties, Barfresh Food Group, iTonic Holdings, Akanda Corp, and Reservoir Media.